Abnormalities of the Immune System Induced by Dysregulated bcl-2 Expression in Transgenic Mice

This publication has 13 references indexed in Scilit:

• bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation
  Cell, 1989
• Evolution of B-cell malignancy: pre-B-cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL2 gene.
  Proceedings of the National Academy of Sciences, 1988
• The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells.
  The Journal of Experimental Medicine, 1988
• Regulation of bcl-2 Proto-Oncogene Expression During Normal Human Lymphocyte Proliferation
  Science, 1987
• Expression of thebcl-2 gene in mouse B lymphocytic cell lines is differentiation stage specific
  European Journal of Immunology, 1987
• Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation
  Cell, 1986
• The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
  Nature, 1985
• Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.
  Proceedings of the National Academy of Sciences, 1985
• Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome Translocation
  Science, 1984
• Introduction of a μ immunoglobulin gene into the mouse germ line: Specific expression in lymphoid cells and synthesis of functional antibody
  Cell, 1984